Navigation Links
A New Product Offering protection against anthrax

The U.S. Food and Drug Administration is scrutinizing the claims made by a Texas businessman// who is promoting a lotion Bio- Germ .According to the claims made by the businessman Allan Lord, he says that his product can give protection from anthrax . The Bio-Germ Protection kits contain skin lotion, a nasal spray, an aerosol spray and a mask, and sell for $250 online.

According to the company, the lotion, which is made from grapefruit seeds and the oil of an Australian tree, can protect the skin of public safety workers responding to a potential terrorist attack. The aerosol spray can be used to decontaminate a room, and as a nasal spray to treat people who have inhaled spores.

Although some say that the product appears to be a breakthrough and the answer to the anthrax problem.

Initial claims on the effectiveness of the product were based on the research of Dr. John Heggers, a burn specialist at the UT Medical Branch in Galveston. Heggers published the only scientific article on Bio-Germ in an obscure online journal run by two of his former medical residents. However the journal was forced to retract the study after two scientists listed as co-authors disputed the articles findings, saying they had never read or approved it.

A number of anthrax experts who reviewed the original article for the newspaper, placed little value on Heggers claims because he failed to test spores of a highly infectious form of anthrax used by terrorists 2001. Most experts were of the opinion that Heggers tested a weak form of the bacteria sometimes found in livestock carcasses and those that could be easily killed by just rubbing alcohol.

Although Hegger has admitted that he exaggerated his claims and says he failed in adhering to the facts, Allan Lord refuses to comment on the newspapers findings, referring questions to the products' developer, who said he was unaware that Bio-Germ was being sold, as the products are still being tested.

If in the FDAs view Bio-Germ is deemed to be violating the law, it could stop the company selling the products, or refer the matter to federal prosecutors. The Federal Trade Commission also could seek penalties if it determines that Bio-Germ has made false or unsubstantiated claims. Hence until officials review the findings of a scientific integrity committee will they decide whether to discipline or fire Heggers, a tenured professor.


'"/>




Related medicine news :

1. Teens Misusing Nicotine-Replacement Products
2. Weight-loss Products Dangerous
3. The Effectiveness Of Antibacterial Products In Reducing Infection
4. Low Fat Dairy Products Ideal For Patients With Gout
5. Dairy Products Reduce Risk Of Type 2 Diabetes In Men
6. With More Appearance Conscious Consumers The Need For Slimming Products Is Rapidly Rising
7. Therapeutic Monoclonal Antibody Production Is More Profitable Than Small Molecule Drugs
8. Tea Found To Boost Insulin Production And Prevent Cataract
9. Cheese Products Withdrawn From Sales Due To Food Poisoning Hazard
10. Conroy’s May Not Be Permitted To Resume Production Soo
11. Massive Production Of Bird Flu Vaccine To Be Initiated In China
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
Breaking Medicine Technology: